Publications by authors named "Gal Bitan"

Claim this Profile
A
Allosteric Modulation of Pathological Ataxin-3 Aggregation: A Path to Spinocerebellar Ataxia Type-3 Therapies.
Alexandra Silva, Sara Duarte-Silva, Pedro M Martins, Beatriz Rodrigues, Débora Serrenho, Gal Bitan

Adv Sci (Weinh)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lysine-Targeting Inhibitors of Amyloidogenic Protein Aggregation: A Promise for Neurodegenerative Proteinopathies.
Kazuma Murakami, Thi Hong Van Nguyen, Chioko Nagao, Kenji Mizuguchi, Gal Bitan

JACS Au· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broad repetitive transcranial magnetic stimulation (rTMS) of the precuneus in Alzheimer's disease: A rationale and study design.
Michael K Leuchter, Hanadi A Oughli, Kelly A Durbin, Nicholas J Jackson, David Elashoff, Gal Bitan

Alzheimers Dement (N Y)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allosteric Modulation of Pathological Ataxin-3 Aggregation: A Path to Spinocerebellar Ataxia Type-3 Therapies.
Alexandra Silva, Sara Duarte-Silva, Pedro M Martins, Beatriz Rodrigues, Débora Serrenho, Gal Bitan

bioRxiv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Extracellular vesicles: emerging roles in the aged and neurodegenerative brain.
Foteini Vasilopoulou, Jennifer Pocock, Gal Bitan, Dirk M Hermann

Front Cell Neurosci· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-amyloid treatment is broadly effective in neuronopathic mucopolysaccharidoses and synergizes with gene therapy in MPS-IIIA.
Marianna Giaccio, Antonio Monaco, Laura Galiano, Andrea Parente, Luigi Borzacchiello, Gal Bitan

Mol Ther· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent advances and future therapy development for Alzheimer's disease and related disorders.
Megan Hong, Gal Bitan

Neural Regen Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anakinra in Sanfilippo syndrome: a phase 1/2 trial.
Lynda E Polgreen, Agnes H Chen, Youngju Pak, Anna Luzzi, Adolfo Morales Garval, Gal Bitan

Nat Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Anakinra in Sanfilippo syndrome: a phase 1/2 trial.
Lynda E Polgreen, Agnes H Chen, Youngju Pak, Anna Luzzi, Adolfo Morales Garval, Gal Bitan

Nat Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel avenues of tau research.
Claire E Sexton, Gal Bitan, Kathryn R Bowles, Miroslaw Brys, Luc Buée

Alzheimers Dement· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Molecular Tweezer Binding on α-Synuclein with Native Top-Down Mass Spectrometry and Ion Mobility-Mass Spectrometry Reveals a Mechanism for Aggregation Inhibition.
Carter Lantz, Jaybree Lopez, Andrew K Goring, Muhammad A Zenaidee, Karl Biggs, Gal Bitan

J Am Soc Mass Spectrom· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IM-MS and ECD-MS/MS Provide Insight into Modulation of Amyloid Proteins Self-Assembly by Peptides and Small Molecules.
Hash Brown Taha, Esha Chawla, Gal Bitan

J Am Soc Mass Spectrom· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers for parkinsonian disorders in CNS-originating EVs: promise and challenges.
Suman Dutta, Simon Hornung, Hash Brown Taha, Gal Bitan

Acta Neuropathol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Novel Electrochemiluminescence ELISA for Quantification of α-Synuclein Phosphorylated at Ser in Biological Samples.
Suman Dutta, Simon Hornung, Hash Brown Taha, Karl Biggs, Ibrar Siddique, Gal Bitan

ACS Chem Neurosci· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Tweezers: Supramolecular Hosts with Broad-Spectrum Biological Applications.
Hedieh Shahpasand-Kroner, Ibrar Siddique, Ravinder Malik, Gabriel R Linares, Magdalena I Ivanova, Gal Bitan

Pharmacol Rev· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward a biomarker panel measured in CNS-originating extracellular vesicles for improved differential diagnosis of Parkinson's disease and multiple system atrophy.
Hash Brown Taha, Simon Hornung, Suman Dutta, Leony Fenwick, Otmane Lahgui, Gal Bitan

Transl Neurodegener· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Trends in biomarkers for neurodegenerative diseases: Current research and future perspectives.
Suman Dutta, Miriam Sklerov, Charlotte E Teunissen, Gal Bitan

Front Aging Neurosci· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Amyloid Inhibitor CLR01 Relieves Autophagy and Ameliorates Neuropathology in a Severe Lysosomal Storage Disease.
Antonio Monaco, Veronica Maffia, Nicolina Cristina Sorrentino, Irene Sambri, Yulia Ezhova, Gal Bitan

Mol Ther· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using FRET-Based Biosensor Cells to Study the Seeding Activity of Tau and α-Synuclein.
Katherine N Maina, Caroline Smet-Nocca, Gal Bitan

Methods Mol Biol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction for "Comparison of Three Amyloid Assembly Inhibitors: The Sugar -Inositol, the Polyphenol Epigallocatechin Gallate, and the Molecular Tweezer CLR01".
Sharmistha Sinha, Zhenming Du, Panchanan Maiti, Frank-Gerrit Klärner, Thomas Schrader, Gal Bitan

ACS Chem Neurosci· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Exosomes: Message in a vesicle.
Suman Dutta, Satish Balasaheb Nimse, Kendall Van Keuren-Jensen, Gal Bitan

Front Pharmacol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A minute fraction of α-synuclein in extracellular vesicles may be a major contributor to α-synuclein spreading following autophagy inhibition.
Hash Brown Taha, Brian Kearney, Gal Bitan

Front Mol Neurosci· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mTOR Inhibition with Sirolimus in Multiple System Atrophy: A Randomized, Double-Blind, Placebo-Controlled Futility Trial and 1-Year Biomarker Longitudinal Analysis.
Jose-Alberto Palma, Jose Martinez, Patricio Millar Vernetti, Thong Ma, Miguel A Perez, Gal Bitan

Mov Disord· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-repeat and four-repeat tau isoforms form different oligomers.
Hedieh Shahpasand-Kroner, Jennifer Portillo, Carter Lantz, Paul M Seidler, Natalie Sarafian, Gal Bitan

Protein Sci· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aptamers targeting amyloidogenic proteins and their emerging role in neurodegenerative diseases.
Kazuma Murakami, Naotaka Izuo, Gal Bitan

J Biol Chem· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis